The Relationship Between Disease Activity, Vegf, E-selectin Levels and Arterial Stiffness in Patients with Rheumatic Diseases

The Relationship Between Disease Activity, Vegf, E-selectin Levels and Arterial Stiffness in Patients with Rheumatic Diseases

Introduction:The endothelial damage, changes in vascular permeability and plaque formation are caused by the effects of cytokines and chemokines that plays role in chronic inflammation in rheumatoid arthritis (RA) and ankylosing spondylitis (AS). It has been reported that arterial stiffness and the...

Full description

Bibliographic Details
Main Authors:	Hüseyin Baygın, Gökhan Sargın, Taşkın Şentürk, Hakan Akdam, Mustafa Yılmaz
Format:	Article
Language:	English
Published:	Galenos Yayinevi 2019-07-01
Series:	İstanbul Medical Journal
Subjects:	Rheumatoid arthritis ankylosing spondylitis arterial stiffness vascular endothelial growth factor E-selectin disease activity
Online Access:	http://imj.galenos.com.tr/archives/archive-detail/article-preview/the-relationship-between-disease-activity-vegf-e-s/29826

Similar Items

Persistence and costs with subcutaneous TNF-alpha inhibitors in immune-mediated rheumatic disease stratified by treatment line
by: Svedbom A, et al.
Published: (2017-01-01)

Intestinal microsporidiosis: a hidden risk in rheumatic disease patients undergoing anti-tumor necrosis factor therapy combined with disease-modifying anti-rheumatic drugs?
by: Nadia Emi Aikawa, et al.
Published: (2011-01-01)

Systemic Inflammatory Response and Atherosclerosis: The Paradigm of Chronic Inflammatory Rheumatic Diseases
by: Aikaterini Arida, et al.
Published: (2018-06-01)

Evaluation of the safety and satisfaction of rheumatic patients with accelerated infliximab infusion
by: Jozélio Freire de Carvalho, et al.
Published: (2018-08-01)

Influence of age on the occurrence of adverse events in rheumatic patients at the onset of biological treatment: data from the BIOBADASER III register
by: Paloma Vela, et al.
Published: (2020-06-01)

Temporomandibular joint dysfunction in various rheumatic diseases
by: F.J. Aceves-Avila, et al.
Published: (2013-07-01)

Histopathology of the gut in rheumatic diseases
by: F. Macaluso, et al.
Published: (2018-10-01)

Characteristic of no-synthase of peripheral blood lymphocytes of patients with rheumatic pathology
by: Ulyana Efremova, et al.
Published: (2015-03-01)

The troubling liaison between cancer and metabolic syndrome in chronic inflammatory rheumatic diseases
by: Giovanni Cioffi, et al.
Published: (2021-03-01)

Body Mass Index and Disease Activity in Chronic Inflammatory Rheumatic Diseases: Results of the Cardiovascular in Rheumatology (Carma) Project
by: Jesús A. Valero-Jaimes, et al.
Published: (2021-01-01)

What is the Frequency of Internet Searches by Patients with Rheumatic Diseases? To What Degree are the Websites They Get Information from Reliable and What is the Effect of These Websites on Their Treatment?
by: Aysel Gürcan Atçı, et al.
Published: (2020-07-01)

Spectrum of central nervous system involvement in rheumatic diseases: pictorial essay
by: Renata Mendes Vieira, et al.
Published: (2018-07-01)

Coexistence of rheumatoid arthritis and ankylosing spondylitis
by: Tacjana Anna Barczyńska, et al.
Published: (2015-12-01)

Treatment persistence of subcutaneous TNF inhibitors among Australian patients with immune-mediated rheumatic disease (IMRD)
by: Acar M, et al.
Published: (2018-11-01)

The Role of Gamma Delta T Cells in Autoimmune Rheumatic Diseases
by: Ilan Bank
Published: (2020-02-01)

Sarcopenia in Patients with Rheumatic Diseases: Prevalence and Associated Risk Factors
by: Michele Barone, et al.
Published: (2018-12-01)

A comparative study of total knee arthroplasty outcome for stiff knee with or without sequential antirheumatic drug treatment
by: Cheng-Qi Jia, et al.
Published: (2021-08-01)

Comorbidities in inflammatory joint and spine diseases in XXI century
by: I Z Gaydukova, et al.
Published: (2018-12-01)

IL-23 and Th17 Disease in Inflammatory Arthritis
by: Toru Yago, et al.
Published: (2017-08-01)

IL-23/IL-17 INHIBITORS IN IMMUNOINFLAMMATORY RHEUMATIC DISEASES: NEW HORIZONS
by: E. L. Nasonov, et al.
Published: (2019-09-01)

Association Between Nursing Support Levels and Effectiveness of Golimumab in the Management of Patients with Rheumatologic Diseases
by: Hermine Leroi, et al.
Published: (2020-05-01)

NEW POSSIBILITIES OF PHARMACOTHERAPY FOR IMMUNOINFLAMMATORY RHEUMATIC DISEASES: A FOCUS ON INHIBITORS OF INTERLEUKIN-17
by: E. L. Nasonov
Published: (2017-03-01)

Frequency of the use of biological treatment of patients with rheumatoid arthritis and ankylosing spondylitis in Lower Silesia
by: Wojciech Tański, et al.
Published: (2016-09-01)

TEMPOROMANDIBULAR JOINT INVOLVEMENT IN RHEUMATOID ARTHRITIS AND ANKYLOSING SPONDYLITIS: A CROSS-SECTIONAL STUDY
by: Cristina Iordache, et al.
Published: (2018-01-01)

SPONTANEOUS IMMUNOGLOBULIN-SYNTHESIZING ACTIVITY OF B LYMPHOCYTES IN INFLAMMATORY RHEUMATIC DISEASES
by: A.T. T. Mamasaidov, et al.
Published: (2014-07-01)

Rheumatic manifestations of endocrine diseases: skeletal diseases in hypoparathyroidism
by: Viktoria Georgiyevna Barskova, et al.
Published: (2013-10-01)

Rheumatic manifestations of endocrine diseases: skeletal diseases in hypoparathyroidism
by: Viktoria Georgiyevna Barskova, et al.
Published: (2013-10-01)

Association between use of disease-modifying antirheumatic drugs and diabetes in patients with ankylosing spondylitis, rheumatoid arthritis, or psoriasis/psoriatic arthritis: a nationwide, population-based cohort study of 84,989 patients
by: Chen HH, et al.
Published: (2017-05-01)

Disease Differentiation and Monitoring of Anti-TNF Treatment in Rheumatoid Arthritis and Spondyloarthropathies
by: Katarzyna Bogunia-Kubik, et al.
Published: (2021-07-01)

Serum heat-shock protein-65 antibody levels are elevated but not associated with disease activity in patients with rheumatoid arthritis and ankylosing spondylitis
by: Ulusoy H, et al.
Published: (2018-05-01)

CONSERVATIVE ORTHOPEDIC TREATMENT OF RHEUMATIC DISEASES: RHEUMATOID ARTHRITIS, ANKYLOSING SPONDYLITIS, OSTEOARTHROSIS, SOFT TISSUE DISEASES (PART II)
by: V P Pavlov
Published: (2009-06-01)

Efficacy, safety and immunogenicity of a trivalent inactivated split influenza vaccine in patients with rheumatic diseases
by: D. V. Bukhanova, et al.
Published: (2018-07-01)

Evaluation of the oxidation-nitrosyl stress manifestations at systematic connective tissue diseases
by: L. A. Alexandrova, et al.
Published: (2016-03-01)

THE FIRST EXPERIENCE IN USING ADALIMUMAB IN PATIENTS WITH ANKYLOSING SPONDYLITIS: CLINICAL AND MRICOMPARISONS OF THE RESULTS OF THERAPY
by: A G Bochkova, et al.
Published: (2010-02-01)

Effect of biologics in the level of cytokines in the synovial fluid of patients with ankylosing spondylitis
by: Bon San Koo, et al.
Published: (2020-03-01)

Distinctive Expression of Bone Metabolism-related Genes between PBMCs from Condylar Hyperplasia, Rheumatoid Arthritis, and Ankylosing Spondylitis Patients
by: Reza Amirzargar, et al.
Published: (2020-10-01)

Machine learning-based prediction model for responses of bDMARDs in patients with rheumatoid arthritis and ankylosing spondylitis
by: Seulkee Lee, et al.
Published: (2021-10-01)

Soluble selectins and highly fucosylated ?1-antichymotrypsin in rheumatoid arthritis patients
by: Anna Olewicz-Gawlik, et al.
Published: (2015-03-01)

Carbohydrate metabolism disorders in patients with rheumatoid arthritis and ankylosing spondylitis – impact of the severity of the inflammatory process and disease activity
by: Piotr Dąbrowski, et al.
Published: (2014-03-01)

Tooth Loss Is Associated with Disease-Related Parameters in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis—A Cross-Sectional Study
by: Gerhard Schmalz, et al.
Published: (2021-07-01)